-+ 0.00%
-+ 0.00%
-+ 0.00%

SCILEX HOLDING COMPANY ANNOUNCES FDA HAS APPROVED OUR REQUEST FOR THE ORPHAN DRUG DESIGNATION FOR COLCHICINE FOR THE TREATMENT OF PERICARDITIS

Reuters·04/16/2025 18:12:04

Please log in to view news